The Role of Some Chemokines from the CXC Subfamily in a Mouse Model of Diabetic Neuropathy

Figure 2

Changes in mRNA amount of chemokines from CXC subfamily after streptozotocin administration measured at day 7 in the mouse lumbar (L4–L6) part of the spinal cord. The qRT-PCR analysis of cxcl1 (a), cxcl5 (b), cxcl9 (c), cxcl11 (d), cxcl12 (e), and cxcl13 (f) expression in naïve and streptozotocin- (STZ-) treated animals. The data are presented as fold change in the control (naïve) ± S.E.M. (4–10 samples per group). The results were evaluated using Student’s -test. and indicate a significant difference compared with naïve mice. STZ, streptozotocin-induced diabetic neuropathy.

(a)

(b)

(c)

(d)

(e)

(f)